Self-protection of individual CD4+ T cells against R5 HIV-1 infection by the synthesis of anti-viral CCR5 ligands.
It is well established that paracrine secretion of anti-viral CCR5 ligands by CD8+ and CD4+ T cells can block the infection of activated CD4+ T cells by R5 and dual-tropic isolates of HIV-1. By contrast, because CD4+ T cells can be infected by HIV-1 and at least some subsets secrete anti-viral CCR5...
Prif Awduron: | Yongjun Guan, Sayed Abdelwahab, Roberta Kamin-Lewis, Anthony L DeVico, George K Lewis |
---|---|
Fformat: | Erthygl |
Iaith: | English |
Cyhoeddwyd: |
Public Library of Science (PLoS)
2008-01-01
|
Cyfres: | PLoS ONE |
Mynediad Ar-lein: | http://europepmc.org/articles/PMC2567041?pdf=render |
Eitemau Tebyg
-
The first structure of HIV-1 gp120 with CD4 and CCR5 receptors
gan: Yongjun Guan
Cyhoeddwyd: (2019-01-01) -
CCR5 Targeted Cell Therapy for HIV and Prevention of Viral Escape
gan: Gero Hütter, et al.
Cyhoeddwyd: (2015-07-01) -
CD4-Induced epitopes in HIV infection
gan: Hudacik Lauren, et al.
Cyhoeddwyd: (2006-12-01) -
Gene editing CCR5 in HIV subjects CD4 T cells
gan: D. Ando
Cyhoeddwyd: (2015-12-01) -
People with HIV have higher percentages of circulating CCR5+ CD8+ T cells and lower percentages of CCR5+ regulatory T cells
gan: Louise E. van Eekeren, et al.
Cyhoeddwyd: (2022-07-01)